Participated · Series B · Apr 2023

SentiAR develops augmented reality visualization technology for medical procedures, centered on its CommandEP product that creates real-time 3D holographic views of patient anatomy. CommandEP integrates existing imaging systems and uses a headset to provide hands-free manipulation of patient data and live catheter locations during cardiac ablation. The system gives physicians a 360-degree interactive view of heart anatomy and has been shown to improve navigation accuracy in the heart by up to 50%. The company says the new funding will support additional partnerships and wider clinical deployments of CommandEP. SentiAR is based in St. Louis, Missouri, and positions its technology as a workflow-friendly AR tool designed not to impede clinical procedures. The company highlights clinical and strategic collaborations as central to its commercialization plans. SentiAR develops a mixed-reality visualization platform for use during interventional procedures, beginning with cardiac ablation and treatment of atrial fibrillation. Its FDA 510(k) cleared CommandEP system receives imaging data from electroanatomic mapping systems and creates a 3D holographic image via proprietary data-flow and visualization algorithms. The patented system displays real-time catheter positions in the patient’s heart through a wearable headset and relies on a custom AR engine for performance. SentiAR’s technology was spun out of Washington University in St. Louis by Dr. Jennifer Silva and Dr. Jonathan Silva. Led by CEO Berk Tas, the company plans to use new funding to accelerate innovation on the CommandEP system.

Participated · Seed · Mar 2023

Healium, based in Columbia, MO, develops patented virtual and augmented reality biofeedback technology that connects biometric data from hardware-agnostic consumer wearables to modify and recommend 3D objects in the metaverse. Led by CEO Sarah Hill, who developed the technology with Dr. Jeff Tarrant in 2016, the company offers products including Sleepium that let users see and interact with real-time EEG patterns, heart rate, skin conductance, blood pressure and other biomarkers. Their iOS and Android apps currently work with Apple Watch and consumer EEG headbands, with more fitness tracker compatibility planned. Healium's products are used worldwide in schools, with frontline healthcare workers, elite athletes, and the U.S. military to self-manage anxiety, burnout, and prepare for sleep or stressful events. The company has a know-how agreement with Mayo Clinic to provide subject matter experts for developing immersive mental health and fitness capabilities. Healium closed a $3.6M seed round and is using the funds to expand operations and accelerate development. Healium combines virtual reality, augmented reality and wearable biometric sensors (including Apple Watch and brain‑sensing headbands) to deliver immersive, biometrically driven stories and neuromeditation designed to calm users. Peer‑reviewed studies cited by the company found Healium can reduce moderate anxiety by about one‑third and increase feelings of positivity in as little as four minutes. The app feeds heart‑rate and brain‑pattern data (e.g., gamma asymmetry) into interactive AR/VR scenes so users can see immediate environmental responses to lowered heart rate or calmer brain activity. Healium began at StoryUp Studios under CEO Sarah Hill and launched as a startup in 2015; the company is based in Columbia, Missouri. The product lineup includes Healium AR ($5/month) and Healium VR ($29/month); the company reports more than $800,000 in revenue to date and has had organizational customers such as the U.S. Navy. Healium also holds issued and pending patents and positions itself as a drugless, self‑management tool for anxiety.